Thioamide-modified peptides and uses thereof
US-11891425-B2 · Feb 6, 2024 · US
US10183967B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10183967-B2 |
| Application number | US-201414766849-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 11, 2014 |
| Priority date | Feb 12, 2013 |
| Publication date | Jan 22, 2019 |
| Grant date | Jan 22, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are methods for refolding proteins that are denatured. Exemplary methods comprise solubilizing the denatured protein with a denaturing agent, e.g., a chaotropic agent, and renaturing the protein using a buffer exchanging system, e.g., tangential flow filtration (TFF).
Opening claim text (preview).
The invention claimed is: 1. A method for refolding a denatured protein, e.g., that is present in inclusion bodies (IBs), comprising (i) providing the denatured protein that is present in IBs, wherein the protein comprises a tenth fibronectin type III ( 10 Fn3) domain and an Fc region; (ii) suspending denatured protein in a suspension solution, to obtain a composition comprising suspended denatured protein; (iii) combining the composition comprising suspended denatured protein with a solubilization buffer that comprises a denaturing agent and has a pH in the range of 7 to 10, wherein the denaturing agent is guanidine or guanidinium, to obtain a first protein composition comprising solubilized denatured protein; (iv) diafiltering the first protein composition comprising solubilized denatured protein with 2-4 diavolumes of a refold buffer that comprises arginine and has a pH in the range of 9 to 11 to obtain a second protein composition comprising partially refolded protein; and (v) incubating the second protein composition comprising partially refolded protein with a refold/oxidizing buffer that comprises arginine and glutathione and has a pH in the range of 9 to 11 to obtain a third protein composition comprising the protein in a refolded state. 2. The method of claim 1 , wherein step (v) comprises diafiltering the second protein composition with 2-6 diavolumes of a refold/oxidizing buffer. 3. The method of claim 1 , wherein diafiltering with refold buffer takes between 0.5 to 3 hours. 4. The method of claim 2 , wherein the diafiltering with the refold/oxidizing buffer takes between 0.5 to 3 hours. 5. The method of claim 1 , wherein the denatured protein is suspended in a suspension solution at a ratio of weight (grams) of denatured protein:volume (ml) of suspension solution of 1:1-10. 6. The method of claim 1 , wherein the composition comprising solubilized denatured protein is not diluted prior to diafiltering. 7. The method of claim 1 , wherein the composition comprising solubilized denatured protein is filtered prior to diafiltering. 8. The method of claim 1 , wherein the third protein composition comprises 1-10 mg/ml of protein. 9. The method of claim 1 , wherein the protein in refolded state has an efficiency of recovery is at least about 70%. 10. The method of claim 1 , wherein the denatured protein comprises at least one disulfide bond. 11. The method of claim 1 , wherein the solubilization buffer, refold buffer, and/or refold/oxidizing buffer comprises Tris.
Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto · CPC title
by filtration, ultrafiltration or reverse osmosis · CPC title
by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents · CPC title
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG] · CPC title
Constant or Fc region; Isotype · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.